---
title: "Patient FAQ — Safety, Compensation, What to Expect | Amavita Research"
url: https://md.amavitaresearch.com/faq-patients
canonical: https://www.amavitaresearch.com/faq-patients
schema_type: FAQPage
last_updated: 2026-05-12
---

# Patient FAQ — Amavita Research

Honest answers for patients considering a cardiovascular clinical trial at Amavita Research in Miami.

## 1. Will I be paid to participate?

For most trials, yes. Compensation typically covers time, transportation, and parking — usually $50–$200 per visit, totals $300–$2,500 depending on trial length and visit count. Exact amount disclosed in the informed consent form before you join. Some trials cover meals or childcare during long visits.

## 2. Is the trial safe?

Every trial at Amavita Research is reviewed by an independent Institutional Review Board (IRB) before it opens. Each trial has a designated principal investigator (a cardiologist), a study coordinator, and 24/7 access to medical care. All trials follow ICH-GCP E6(R3) — the international gold standard for patient safety.

## 3. What happens if I have a side effect?

Call the study coordinator listed on your consent form (24/7 number). Adverse events documented within 24 hours, evaluated by your PI, reported to IRB and sponsor on required timelines. Care for trial-related side effects is provided regardless of cost.

## 4. Can I leave a trial after I enroll?

Yes — at any time, for any reason. No penalties, no costs. Your standard cardiology care at amavita Heart and Vascular Health® continues unchanged.

## 5. Will the trial affect my regular cardiology care?

No. Trial participation is in addition to standard care, not a replacement. Your regular cardiologist stays involved. Study team reviews investigational treatments alongside your normal medications.

## 6. Do I need insurance to participate?

No. Trial-related visits, tests, medications, and the investigational treatment are paid for by the sponsor.

## 7. Is my health information kept private?

Yes. HIPAA-compliant. Your name is replaced with a study ID number in records sent to the sponsor. Information is not sold or used for marketing.

## 8. How do I find a trial I might be eligible for?

Visit https://www.amavitaresearch.com/trials or call (786) 703-5941 to speak with a study coordinator. Most trials require a brief in-person eligibility visit, which is free.

## 9. Who's the doctor running my trial?

Dr. William W. O'Neill, Dr. Pedro Martinez-Clark, Dr. Hans C. Rutzen-Lopez, or another board-certified cardiologist depending on the indication.

## 10. What's the time commitment?

Typical cardiovascular feasibility trial: 6–12 visits over 6 to 24 months. Each visit 1–3 hours. Some trials add phone check-ins between visits.

## 11. Can I keep the investigational drug or device after the trial ends?

Usually no. If FDA approves it after the trial, your coordinator can help you access it commercially. Some sponsors offer extended-access programs.

## 12. What if I'm not eligible for a current trial?

We can add you (with your permission) to a screening registry for upcoming cardiovascular trials. No cost, removable any time by calling (786) 703-5941 or emailing research@amavita.health.